00000000cam 2200000zi 4500
0019.965448
003CaOODSP
00520260924133125
006m     o  d f      
007cr cn|||||||||
008250826s2025    onca    os   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
0410 |aeng|afre
043 |an-cn---
045 |ay0y2
0861 |aH82-63/2025-PDF
1001 |aYang, Jihong, |eauthor.
24510|aNavigating the market landscape for rare disease drugs in Canada / |cJihong Yang, Tuhin Rahman and Shirin Rizzardo = Comprendre le marché des medicaments pour maladies rares au Canada / Jihong Yang, Tuhin Rahman et Shirin Rizzardo.
24611|aComprendre le marché des medicaments pour maladies rares au Canada
264 1|a[Ottawa] : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c[2025]
300 |a1 online resource (1 page) : |bcolour illustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |a"NPDUIS, National Prescription Drug Utilization Information System."
520 |a"The emergence of a growing number of expensive drugs for rare diseases (EDRDs) presents new treatment possibilities while raising concerns around affordability and access. This study analyzes EDRDs launched in Canada over the past two decades, using quantitative data to evaluate EDRD trends in drug approvals, drug prices and sales revenues in Canada"--Objective.
546 |aText in English and French.
650 0|aOrphan drugs|zCanada|vStatistics.
650 0|aOrphan drugs|xPrices|zCanada|vStatistics.
650 0|aDrug approval|zCanada|vStatistics.
650 0|aPharmaceutical industry|zCanada|vStatistics.
655 7|aStatistics|2lcgft
7101 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body.
788 |tNavigating the market landscape for rare disease drugs in Canada / |efre|w(CaOODSP)9.966228
85640|qPDF|s533 KB|uhttps://publications.gc.ca/collections/collection_2026/cepmb-pmprb/H82-63-2025.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/posters/navigating-market-landscape.html